A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).
OBJECTIVE: To refine and validate the Birmingham Vasculitis Activity Score (BVAS) as a disease-specific activity index for Wegener's granulomatosis (WG). METHODS: Sixteen members of the International Network for the Study of the Systemic Vasculitides (INSSYS) revised the BVAS, with 3 goals: to...
| Autors principals: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Idioma: | English |
| Publicat: |
2001
|
| _version_ | 1826271118504230912 |
|---|---|
| author | Stone, J Hoffman, G Merkel, P Min, Y Uhlfelder, M Hellmann, D Specks, U Allen, N Davis, J Spiera, R Calabrese, L Wigley, F Maiden, N Valente, R Niles, J Fye, K McCune, J St Clair, E Luqmani, R |
| author_facet | Stone, J Hoffman, G Merkel, P Min, Y Uhlfelder, M Hellmann, D Specks, U Allen, N Davis, J Spiera, R Calabrese, L Wigley, F Maiden, N Valente, R Niles, J Fye, K McCune, J St Clair, E Luqmani, R |
| author_sort | Stone, J |
| collection | OXFORD |
| description | OBJECTIVE: To refine and validate the Birmingham Vasculitis Activity Score (BVAS) as a disease-specific activity index for Wegener's granulomatosis (WG). METHODS: Sixteen members of the International Network for the Study of the Systemic Vasculitides (INSSYS) revised the BVAS, with 3 goals: to reduce the redundancy of some component items, to enhance its ability to capture important disease manifestations specific to WG, and to streamline the instrument for use in clinical research. We defined the items and weighted them empirically as either minor (e.g., nasal crusting = 1 point) or major (e.g., alveolar hemorrhage = 3 points). We then validated the new, disease-specific BVAS/WG in 2 simulation exercises and a clinical case series that involved 117 patients with WG. RESULTS: We removed 38 items from the original BVAS, revised 9 items, and added 7 new items. Correlations between the scores on the BVAS/WG and the physician's global assessment (PGA) of disease activity were high, even when patients in remission were excluded. In the clinical case series, Spearman's rank correlation coefficient between the BVAS/WG and the PGA was r = 0.81 (95% confidence interval 0.73-0.87). The interobserver reliability using intraclass (within-case) correlation coefficients in the 2 simulation exercises was r = 0.93 for the BVAS/WG and r = 0.88 for the PGA in the first and r = 0.91 for the BVAS/WG and r = 0.88 for the PGA in the second. There was no significant observer effect in the scoring of the BVAS/WG or the PGA. The discriminant validity of the BVAS/WG was good: r = 0.73 (95% confidence interval 0.43-0.83). CONCLUSION: The BVAS/WG is a valid, disease-specific activity index for WG. Tested in simulation exercises and in actual patients, the BVAS/WG correlates well with the PGA, is sensitive to change, and has good inter- and intraobserver reliability. The INSSYS will use the BVAS/WG to assess the primary outcome in a phase II/III trial of etanercept in WG. |
| first_indexed | 2024-03-06T21:51:36Z |
| format | Journal article |
| id | oxford-uuid:4b78c2b2-b0aa-444c-8a72-d9dd9eb7865a |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:51:36Z |
| publishDate | 2001 |
| record_format | dspace |
| spelling | oxford-uuid:4b78c2b2-b0aa-444c-8a72-d9dd9eb7865a2022-03-26T15:43:47ZA disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4b78c2b2-b0aa-444c-8a72-d9dd9eb7865aEnglishSymplectic Elements at Oxford2001Stone, JHoffman, GMerkel, PMin, YUhlfelder, MHellmann, DSpecks, UAllen, NDavis, JSpiera, RCalabrese, LWigley, FMaiden, NValente, RNiles, JFye, KMcCune, JSt Clair, ELuqmani, R OBJECTIVE: To refine and validate the Birmingham Vasculitis Activity Score (BVAS) as a disease-specific activity index for Wegener's granulomatosis (WG). METHODS: Sixteen members of the International Network for the Study of the Systemic Vasculitides (INSSYS) revised the BVAS, with 3 goals: to reduce the redundancy of some component items, to enhance its ability to capture important disease manifestations specific to WG, and to streamline the instrument for use in clinical research. We defined the items and weighted them empirically as either minor (e.g., nasal crusting = 1 point) or major (e.g., alveolar hemorrhage = 3 points). We then validated the new, disease-specific BVAS/WG in 2 simulation exercises and a clinical case series that involved 117 patients with WG. RESULTS: We removed 38 items from the original BVAS, revised 9 items, and added 7 new items. Correlations between the scores on the BVAS/WG and the physician's global assessment (PGA) of disease activity were high, even when patients in remission were excluded. In the clinical case series, Spearman's rank correlation coefficient between the BVAS/WG and the PGA was r = 0.81 (95% confidence interval 0.73-0.87). The interobserver reliability using intraclass (within-case) correlation coefficients in the 2 simulation exercises was r = 0.93 for the BVAS/WG and r = 0.88 for the PGA in the first and r = 0.91 for the BVAS/WG and r = 0.88 for the PGA in the second. There was no significant observer effect in the scoring of the BVAS/WG or the PGA. The discriminant validity of the BVAS/WG was good: r = 0.73 (95% confidence interval 0.43-0.83). CONCLUSION: The BVAS/WG is a valid, disease-specific activity index for WG. Tested in simulation exercises and in actual patients, the BVAS/WG correlates well with the PGA, is sensitive to change, and has good inter- and intraobserver reliability. The INSSYS will use the BVAS/WG to assess the primary outcome in a phase II/III trial of etanercept in WG. |
| spellingShingle | Stone, J Hoffman, G Merkel, P Min, Y Uhlfelder, M Hellmann, D Specks, U Allen, N Davis, J Spiera, R Calabrese, L Wigley, F Maiden, N Valente, R Niles, J Fye, K McCune, J St Clair, E Luqmani, R A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). |
| title | A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). |
| title_full | A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). |
| title_fullStr | A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). |
| title_full_unstemmed | A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). |
| title_short | A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). |
| title_sort | disease specific activity index for wegener s granulomatosis modification of the birmingham vasculitis activity score international network for the study of the systemic vasculitides inssys |
| work_keys_str_mv | AT stonej adiseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT hoffmang adiseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT merkelp adiseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT miny adiseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT uhlfelderm adiseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT hellmannd adiseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT specksu adiseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT allenn adiseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT davisj adiseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT spierar adiseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT calabresel adiseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT wigleyf adiseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT maidenn adiseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT valenter adiseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT nilesj adiseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT fyek adiseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT mccunej adiseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT stclaire adiseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT luqmanir adiseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT stonej diseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT hoffmang diseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT merkelp diseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT miny diseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT uhlfelderm diseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT hellmannd diseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT specksu diseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT allenn diseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT davisj diseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT spierar diseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT calabresel diseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT wigleyf diseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT maidenn diseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT valenter diseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT nilesj diseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT fyek diseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT mccunej diseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT stclaire diseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys AT luqmanir diseasespecificactivityindexforwegenersgranulomatosismodificationofthebirminghamvasculitisactivityscoreinternationalnetworkforthestudyofthesystemicvasculitidesinssys |